BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Diagnosis
45 results:

  • 1. Mental health and diet quality after primary treatment for ovarian cancer.
    Johnston EA; Veenhuizen SGA; Ibiebele TI; Webb PM; van der Pols JC;
    Nutr Diet; 2024 Apr; 81(2):215-227. PubMed ID: 38192229
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Glucagon-Like Peptide-1 Receptor Agonists and Pancreatic cancer Risk in Patients With Type 2 Diabetes.
    Dankner R; Murad H; Agay N; Olmer L; Freedman LS
    JAMA Netw Open; 2024 Jan; 7(1):e2350408. PubMed ID: 38175642
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAF
    Lin Y; Luo YK; Li J; Ren XY; Wang HW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The auxiliary diagnosis of thyroid echogenic foci based on a deep learning segmentation model: A two-center study.
    Liu Y; Chen C; Wang K; Zhang M; Yan Y; Sui L; Yao J; Zhu X; Wang H; Pan Q; Wang Y; Liang P; Xu D
    Eur J Radiol; 2023 Oct; 167():111033. PubMed ID: 37595399
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Facilitation of Definitive cancer diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules.
    Fu G; Chazen RS; Monteiro E; Vescan A; Freeman JL; Witterick IJ; MacMillan C
    JAMA Netw Open; 2023 Jul; 6(7):e2323500. PubMed ID: 37505499
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of BRAF, ccnd1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
    Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
    World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.
    Umetsu SE; Kakar S; Basturk O; Kim GE; Chatterjee D; Wen KW; Hale G; Shafizadeh N; Cho SJ; Whitman J; Gill RM; Jones KD; Navale P; Bergsland E; Klimstra D; Joseph NM
    Mod Pathol; 2023 Mar; 36(3):100065. PubMed ID: 36788102
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.
    Jimenez C; Ma J; Roman Gonzalez A; Varghese J; Zhang M; Perrier N; Habra MA; Graham P; Waguespack SG
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1132-1142. PubMed ID: 36433823
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prevalence, features, and explanations of missed and misinterpreted pancreatic cancer on imaging: a matched case-control study.
    Hoogenboom SA; Engels MML; Chuprin AV; van Hooft JE; LeGout JD; Wallace MB; Bolan CW
    Abdom Radiol (NY); 2022 Dec; 47(12):4160-4172. PubMed ID: 36127473
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genetics and Epigenetics of Parathyroid Carcinoma.
    Marini F; Giusti F; Palmini G; Perigli G; Santoro R; Brandi ML
    Front Endocrinol (Lausanne); 2022; 13():834362. PubMed ID: 35282432
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Urinary Free Metanephrines for diagnosis of Pheochromocytoma and Paraganglioma.
    Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Treatment and prognostic factors of pituicytoma: a single-center experience and comprehensive literature review.
    Wei LD; Li C; Li D; Liu XJ; Li RT; Li LW; Wang JM; Zhou DB
    Pituitary; 2021 Oct; 24(5):754-767. PubMed ID: 33982223
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Extra-appendicular neuroendocrine tumors: A report from the TREP project (2000-2020).
    Virgone C; Ferrari A; Chiaravalli S; De Pasquale MD; Inserra A; D'Angelo P; Ogunleye MF; Crocoli A; Vallero S; Cesaro S; Alaggio R; Bisogno G; Dall'Igna P
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28880. PubMed ID: 33522705
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical characteristics and prognostic factors of colorectal cancer patients with ovarian metastasis: a multicenter retrospective study.
    Li X; Zhang W; Ding P; Guo R; Hong Z; Liu P; Wang Z; Yu Y; Fang C; Meng W; Zhang R; Qiu M
    Int J Colorectal Dis; 2021 Jun; 36(6):1201-1208. PubMed ID: 33511478
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pancreatic resections in patients who refuse blood transfusions. The application of a perioperative protocol for a true bloodless surgery.
    De Bellis M; Girelli D; Ruzzenente A; Bagante F; Ziello R; Campagnaro T; Conci S; Nifosì F; Guglielmi A; Iacono C
    Pancreatology; 2020 Oct; 20(7):1550-1557. PubMed ID: 32950387
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MicroRNA‑195 suppresses cell proliferation, migration and invasion in epithelial ovarian carcinoma via inhibition of the CDC42/ccnd1 pathway.
    Hao X; Jia Q; Yuan J; Shi X; Guo H; Gao J; Guo Y
    Int J Mol Med; 2020 Nov; 46(5):1862-1872. PubMed ID: 32901852
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Ovarian mucinous tumors with mural nodules: immunohistochemical and molecular analysis of 3 cases.
    Shao Y; Liu Q; Shi H; Lu B
    Diagn Pathol; 2020 Apr; 15(1):35. PubMed ID: 32290854
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Parathyroid Carcinoma.
    Cetani F; Pardi E; Marcocci C
    Front Horm Res; 2019; 51():63-76. PubMed ID: 30641523
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Accuracy of Intraoperative Frozen Section diagnosis of Borderline Ovarian Tumors by Hospital Type.
    Shah JS; Mackelvie M; Gershenson DM; Ramalingam P; Kott MM; Brown J; Gauthier P; Nugent E; Ramondetta LM; Frumovitz M
    J Minim Invasive Gynecol; 2019 Jan; 26(1):87-93. PubMed ID: 29680231
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology.
    Pfarr N; Darb-Esfahani S; Leichsenring J; Taube E; Boxberg M; Braicu I; Jesinghaus M; Penzel R; Endris V; Noske A; Weichert W; Schirmacher P; Denkert C; Stenzinger A
    Genes Chromosomes Cancer; 2017 Oct; 56(10):758-766. PubMed ID: 28639280
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.